CancerLinQ, LLC CEO, Kevin Fitzpatrick will join leaders of the cancer community including the Cancer Support Community and the American Cancer Society in speaking at the 2017 eyeforpharma Oncology Market Access & Pricing, taking place in Philadelphia.
The two-day summit being held from June 15-16, brings together stakeholders from the larger cancer community to deliver workable solutions to drive better patient outcomes and greater therapy access in the shift from volume to value. The meeting will bring together some of the leading minds in oncology to help pharma take charge and deliver value to its stakeholders.
Fitzpatrick will address the summit during the keynote panel and during an additional session where he will discuss the new era of survivorship and the unique health challenges faced, as cancer care moves towards a chronic condition. He will also discuss these topics through the lens of CancerLinQ®, ASCO’s big-data initiative aimed at unlocking, assembling, and analyzing de-identified patient records to gain insights that can improve the quality of care.
CancerLinQ® is a powerful platform containing ever-growing amounts of real-world cancer information. This national initiative will allow cancer providers to improve the quality and value of care by analyzing millions of cancer patient medical records, uncovering patterns and trends, and measuring their care against that of their peers and recommended guidelines.